Sponsored by
Another successful early trial of a new treatment! They report very early data on five recurrent Glioma patients who have failed all standard treatments. They had one complete response, and two had stable disease. Unfortunately, it appears that this trial is only available in China. Hopefully once it is successful it will be brought to the USA!